0001628280-19-004762.txt : 20190425 0001628280-19-004762.hdr.sgml : 20190425 20190425201200 ACCESSION NUMBER: 0001628280-19-004762 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190423 FILED AS OF DATE: 20190425 DATE AS OF CHANGE: 20190425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Talasaz AmirAli CENTRAL INDEX KEY: 0001753159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 19768989 MAIL ADDRESS: STREET 1: 18 ISABELLA AVENUE CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 wf-form4_155623750501525.xml FORM 4 X0306 4 2019-04-23 0 0001576280 Guardant Health, Inc. GH 0001753159 Talasaz AmirAli 505 PENOBSCOT DRIVE REDWOOD CITY CA 94063 1 1 0 0 Chairman, President and COO COMMON STOCK 2019-04-23 4 S 0 2697 66.06 D 3804080 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-04-23 4 S 0 30710 66.91 D 3773370 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-04-23 4 S 0 8318 67.65 D 3765052 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-04-23 4 S 0 1562 66.35 D 27443 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-23 4 S 0 8044 67.03 D 19399 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-23 4 S 0 1000 67.77 D 18399 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-23 4 S 0 616 66.07 D 28389 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-23 4 S 0 8180 66.92 D 20209 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-23 4 S 0 1810 67.67 D 18399 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-23 4 M 0 15202 4.18 A 19045 D COMMON STOCK 2019-04-23 4 S 0 1410 66.17 D 17635 D COMMON STOCK 2019-04-23 4 S 0 11957 66.92 D 5678 D COMMON STOCK 2019-04-23 4 S 0 3240 67.63 D 2438 D COMMON STOCK 2019-04-24 4 S 0 6778 65.28 D 3758274 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-04-24 4 S 0 10018 66.29 D 3748256 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-04-24 4 S 0 3136 66.92 D 3745120 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-04-24 4 S 0 1886 65.28 D 16513 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-24 4 S 0 2780 66.43 D 13733 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-24 4 S 0 400 66.93 D 13333 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-24 4 S 0 2097 65.43 D 16302 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-24 4 S 0 2869 66.45 D 13433 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-24 4 S 0 100 67.22 D 13333 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-04-24 4 M 0 7454 4.18 A 9892 D COMMON STOCK 2019-04-24 4 S 0 3008 65.30 D 6884 D COMMON STOCK 2019-04-24 4 S 0 4015 66.38 D 2869 D COMMON STOCK 2019-04-24 4 S 0 909 66.99 D 1960 D COMMON STOCK 737800 I Shares held by Talasaz Investments, L.P. STOCK OPTION (RIGHT TO BUY) 4.18 2019-04-23 4 M 0 15202 0 D 2027-07-13 COMMON STOCK 15202.0 1139454 D STOCK OPTION (RIGHT TO BUY) 4.18 2019-04-24 4 M 0 7454 0 D 2027-07-13 COMMON STOCK 7454.0 1132000 D These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.40 to $66.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.40 to $67.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.40 to $68.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.58 to $66.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.67 to $67.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.67 to $68.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.41 to $66.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.42 to $67.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.43 to $68.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares were acquired and then sold contemporaneously upon the cashless exercise of stock option at an exercise price of $4.18 per share. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.44 to $66.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.46 to $67.44 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.46 to $68.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.78 to $65.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.78 to $66.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.78 to $67.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.81 to $65.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.86 to $66.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.86 to $67.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.96 to $65.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.96 to $66.9, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.86 to $65.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.87 to $66.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.90 to $67.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017. /s/ Michael Wiley, as Attorney-in-Fact for AmirAli Talasaz 2019-04-25